Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Adrian Newland, Roy Bentley, Anna Jakubowska, Howard Liebman, Joanna Lorens, Markus Peck-Radosavljevic, Vanessa Taieb, Akiyoshi Takami, Ryosuke Tateishi & Zobair M. Younossi. (2019) A systematic literature review on the use of platelet transfusions in patients with thrombocytopenia. Hematology 24:1, pages 679-719.
Read now
Read now
Sammy Saab, Hélène Parisé, Suchin Virabhak, Alice Wang, Steven E. Marx, Yuri Sanchez Gonzalez, Derek Misurski & Scott Johnson. (2016) Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US. Journal of Medical Economics 19:8, pages 795-805.
Read now
Read now
Viktor V Chirikov, Fadia T Shaya, C Daniel Mullins, Susan dosReis, Ebere Onukwugha & Charles D Howell. (2015) Determinants of quality of care and treatment initiation in Medicare disabled patients with chronic hepatitis C. Expert Review of Gastroenterology & Hepatology 9:11, pages 1447-1462.
Read now
Read now
Fred Poordad, Dickens Theodore, Jane Sullivan & Kelly Grotzinger. (2012) Evaluating medical resource utilization and costs associated with thrombocytopenia in chronic liver disease patients. Journal of Medical Economics 15:1, pages 112-124.
Read now
Read now
Articles from other publishers (12)
Nigel Armstrong, Nasuh Büyükkaramikli, Hannah Penton, Rob Riemsma, Pim Wetzelaer, Vanesa Huertas Carrera, Stephanie Swift, Thea Drachen, Heike Raatz, Steve Ryder, Dhwani Shah, Titas Buksnys, Gill Worthy, Steven Duffy, Maiwenn Al & Jos Kleijnen. (2020) Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis. Health Technology Assessment 24:51, pages 1-220.
Crossref
Crossref
Robert S. BrownJrJr, Roy Bentley, Bin Cai, Steven L. Flamm, Hemanth Kanakamedala, Jennifer Lai, Stephen Marcella, Andrew J. Muir & Kimberly A. Brown. (2019) The clinical and economic burden of patients with chronic liver disease and thrombocytopaenia receiving platelet transfusions during planned invasive procedures. GastroHep 1:5, pages 236-248.
Crossref
Crossref
Viktor V. Chirikov, Fadia T. Shaya, Ebere Onukwugha, C. Daniel Mullins, Susan dosReis & Charles D. Howell. (2017) Tree-based Claims Algorithm for Measuring Pretreatment Quality of Care in Medicare Disabled Hepatitis C Patients. Medical Care 55:12, pages e104-e112.
Crossref
Crossref
Christopher Koh, Sasan Sakiani, Pallavi Surana, Xiongce Zhao, Jason Eccleston, David E. Kleiner, David Herion, T. Jake Liang, Jay H. Hoofnagle, Milica Chernick & Theo Heller. (2017) Adult‐onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity. Hepatology 66:2, pages 591-601.
Crossref
Crossref
Raoel Maan, Remziye Zaim, Adriaan J van der Meer, Jordan J Feld, Heiner Wedemeyer, Jean-François Dufour, Frank Lammert, Michael P Manns, Stefan Zeuzem, Bettina E Hansen, Harry LA Janssen, Bart J Veldt, Robert J de Knegt & Carin A Uyl-de Groot. (2016) Real-world medical costs of antiviral therapy among patients with chronic HCV infection and advanced hepatic fibrosis. Journal of Gastroenterology and Hepatology 31:11, pages 1851-1859.
Crossref
Crossref
Sammy Saab, Yuri S. Gonzalez, Caroline Huber, Alice Wang & Timothy Juday. (2015)
Cost‐effectiveness of Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir+Ribavirin for
US
Post‐Liver Transplant Recurrent Genotype 1
HCV
. Liver International 36:4, pages 515-521.
Crossref
Crossref
Michele M. Tana, Xiongce Zhao, Alyson Bradshaw, Mi Sun Moon, Sandy Page, Tiffany Turner, Elenita Rivera, David E. Kleiner & Theo Heller. (2015) Factors associated with the platelet count in patients with chronic hepatitis C. Thrombosis Research 135:5, pages 823-828.
Crossref
Crossref
Syed-Mohammed R. Jafri & Stuart C. Gordon. (2014) The Consequences of Cirrhosis in America. Digestive Diseases and Sciences 60:2, pages 283-284.
Crossref
Crossref
John A. Hermos, Lien Quach, David R. Gagnon, H. Christian Weber, Arman Altincatal, Kelly Cho, Elizabeth V. Lawler & Kelly M. Grotzinger. (2014) Incident severe thrombocytopenia in veterans treated with pegylated interferon plus ribavirin for chronic hepatitis C infection. Pharmacoepidemiology and Drug Safety 23:5, pages 480-488.
Crossref
Crossref
John A. Hermos, Arman Altincatal, H. Christian Weber, Kelly Grotzinger, Kyle J. Smoot, Kelly Cho, David R. Gagnon & Elizabeth V. Lawler. (2012) Thrombocytopenia and Bleeding in Veterans with Non-hepatitis C-related Chronic Liver Disease. Digestive Diseases and Sciences 58:2, pages 562-573.
Crossref
Crossref
Tatsuo Kanda, Keizo Kato, Akihito Tsubota, Nobuo Takada, Takayoshi Nishino, Shigeru Mikami, Tatsuo Miyamura, Daisuke Maruoka, Shuang Wu, Shingo Nakamoto, Makoto Arai, Keiichi Fujiwara, Fumio Imazeki & Osamu Yokosuka. (2013) Platelet count and sustained virological response in hepatitis C treatment. World Journal of Hepatology 5:4, pages 182.
Crossref
Crossref
Venu Gopala Reddy Gangireddy, Teresa A. Coleman, Akash Nabh & Subbaramiah Sridhar. (2012) Romiplostim in the Management of Thrombocytopenia in a Patient with Autoimmune Hepatitis. Digestive Diseases and Sciences 57:9, pages 2466-2472.
Crossref
Crossref